📊 AYRWF Key Takeaways
Is Ayr Wellness Inc. (AYRWF) a Good Investment?
Insufficient financial data available to conduct meaningful fundamental analysis. The company's SEC filings lack essential income statement, balance sheet, and cash flow metrics required for proper evaluation. Unable to assess profitability trends, financial health, or growth quality due to data unavailability.
Ayr Wellness still generated meaningful scale in 2024, with revenue of about $463.6 million, positive gross profit, and positive operating cash flow, but the business remained deeply unprofitable and entered 2025 with worsening operating trends. The balance sheet and liquidity profile are the core issue: management disclosed substantial doubt about continuing as a going concern in March 2025, and later 2025 EDGAR filings show a debt restructuring, foreclosure sale of core assets to senior lenders, and planned wind-down of the existing parent entity.
Why Buy Ayr Wellness Inc. Stock? AYRWF Key Strengths
- Company filed with SEC (CIK registered)
- Operates in medicinal chemicals sector
- No recent insider selling detected (0 Form 4 filings in 90 days)
- 2024 revenue was stable at about $463.6 million, showing the company still had meaningful operating scale
- Gross profit remained positive in 2024 at about $176.7 million, indicating the core business still produced gross margin before heavy overhead, interest, and impairments
- Operating cash flow stayed positive in 2024 and Q1 2025, which suggests the business retained some cash-generation capacity despite losses
AYRWF Stock Risks: Ayr Wellness Inc. Investment Risks
- Complete absence of revenue and profitability data
- No balance sheet metrics available (assets, equity, debt)
- Impossible to assess liquidity, solvency, or operational cash flow
- Only 1 metric available out of required fundamental data set
- Unable to determine financial viability or operational performance
- Profitability deteriorated sharply, with 2024 net loss widening to about $161.0 million and Q1 2025 revenue and gross profit falling year over year
- Financial health is severely stressed, with negative working capital, large debt and lease obligations, and an explicit going-concern warning in the March 31, 2025 filing
- Later 2025 EDGAR filings show restructuring, missed debt payments, foreclosure sale of core assets to senior noteholders, and expected wind-down of the existing parent entity
Key Metrics to Watch
- Revenue and gross profit trends when data becomes available
- Operating cash flow and free cash flow generation
- Debt-to-equity ratio and liquidity position
- Form 4 insider trading activity
- Quarterly revenue and gross profit trend, especially whether retail and wholesale sales stabilize after the 2025 decline
- Unrestricted cash, working capital, and debt restructuring outcomes including any transfer of assets or remaining obligations at the parent level
Ayr Wellness Inc. (AYRWF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
AYRWF Profit Margin, ROE & Profitability Analysis
AYRWF vs Materials Sector: How Ayr Wellness Inc. Compares
How Ayr Wellness Inc. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Ayr Wellness Inc. Stock Overvalued? AYRWF Valuation Analysis 2026
Based on fundamental analysis, Ayr Wellness Inc. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Ayr Wellness Inc. Balance Sheet: AYRWF Debt, Cash & Liquidity
AYRWF Revenue Growth, EPS Growth & YoY Performance
AYRWF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Ayr Wellness Inc. (CIK: 0001847462)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AYRWF
What is the AI rating for AYRWF?
Ayr Wellness Inc. (AYRWF) has a Combined AI Rating of SELL from Claude (HOLD) and ChatGPT (STRONG SELL) with 51% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AYRWF's key strengths?
Claude: Company filed with SEC (CIK registered). Operates in medicinal chemicals sector. ChatGPT: 2024 revenue was stable at about $463.6 million, showing the company still had meaningful operating scale. Gross profit remained positive in 2024 at about $176.7 million, indicating the core business still produced gross margin before heavy overhead, interest, and impairments.
What are the risks of investing in AYRWF?
Claude: Complete absence of revenue and profitability data. No balance sheet metrics available (assets, equity, debt). ChatGPT: Profitability deteriorated sharply, with 2024 net loss widening to about $161.0 million and Q1 2025 revenue and gross profit falling year over year. Financial health is severely stressed, with negative working capital, large debt and lease obligations, and an explicit going-concern warning in the March 31, 2025 filing.
What is AYRWF's revenue and growth?
Ayr Wellness Inc. reported revenue of N/A.
Does AYRWF pay dividends?
Ayr Wellness Inc. does not currently pay dividends.
Where can I find AYRWF SEC filings?
Official SEC filings for Ayr Wellness Inc. (CIK: 0001847462) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AYRWF's EPS?
Ayr Wellness Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AYRWF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Ayr Wellness Inc. has a SELL rating with 51% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AYRWF stock overvalued or undervalued?
Valuation metrics for AYRWF: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy AYRWF stock in 2026?
Our dual AI analysis gives Ayr Wellness Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AYRWF's free cash flow?
Ayr Wellness Inc.'s operating cash flow is N/A, with capital expenditures of N/A.
How does AYRWF compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).